HEPOID
LIVE

Serial Number

90094968

Owner

SATT OUEST VALORISATION

Attorney

R. Peter Spies

Filing Date

Aug 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HEPOID Trademark

Serial Number: 90094968 • Registration: 6610706

HEPOID is a trademark filed by SATT OUEST VALORISATION on August 5, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SATT OUEST VALORISATION (10 trademarks)

MÉTROPOLIS II 14C RUE DU PÂTIS TATELIN
RENNES 35700 , FR

Entity Type: 99

Trademark Details

Filing Date

August 5, 2020

Registration Date

January 11, 2022

Published for Opposition

October 26, 2021

Goods & Services

Measuring instruments and apparatus for diagnosis, other than for medical use, namely, scientific apparatus and instruments for drug discovery screening; data processing equipment and apparatus; recorded software programs for use in drug discovery screening; apparatus computer equipment apparatus, namely, computer peripheral devices and computers, for medical research and diagnosis and for drug discovery screening; recorded software programs for drug discovery screening; diagnostic devices not for medical use, namely, diagnostic apparatus for conducting tests to assess hepatotoxicity/hepatic metabolism and associated mechanisms; devices for non-medical metabolism testing

Pharmaceutical and veterinary preparations, namely, preparations based on hepatic cell models, preparations in the field of hepatotoxicity and liver disease, preparations for in vivo and in vitro tests, in particular for tests to assess hepatotoxicity/hepatic metabolism and associated mechanisms; hygienic preparations for medicine based on hepatic cell models; chemical preparations for medical or pharmaceutical purposes, namely, preparations for testing or treating hepatotoxicity/hepatic metabolism and associated mechanisms or liver diseases; Cellular preparations for medicine; products made from or derived from cells for medical research; Product based on or derived from hepatic cells, for the performance of toxicity tests for medical purposes

Products made from or derived from hepatic cells for medical research

Medical services

Surgical apparatus and instruments; medical apparatus and instruments for the diagnostic and treatment of liver disease; medical apparatus and instruments for testing metabolism; medical apparatus and instruments using hepatic cell models for disease diagnosis or treatment; medical apparatus and instruments for in vivo and in vitro tests using hepatic cell models; veterinary apparatus and instruments using hepatic cell models for disease diagnosis or treatment; diagnostic apparatus for medical purposes for conducting test using hepatic cell models; apparatus for use in medical analysis, namely, for measuring liver disease and testing metabolism

Evaluations provided by engineers, namely, drug discovery screening; estimates provided by engineers, namely, estimations regarding drug discovery screening; scientific research provided by engineers; technological research in the field of hepatic cells and drug discovery screening provided by engineers; scientific and technological services in the medical and diagnostic field, namely, providing medical testing services and information in the field of hepatic cells; scientific research in the field of diagnostics or for medical purposes; electronic storage of medical records; design, development, maintenance and hosting of databases of medical images and patient data; computer programming in the field of diagnostics or medicine; design and development of medical diagnostic apparatus and equipment; design and development of software for use in medical technology in the field of diagnostics; computer aided diagnostic services in the field of hepatotoxicity and liver disease, computer aided diagnostic services in the field of in vivo and in vitro tests; providing scientific information in the medical field; temporary online provision of non-downloadable operating software allowing access to a computer network; software as a service; services featuring software in the field of diagnostics or medicine for processing and displaying data resulting from drug discovery screening; research and development of new products for others; technical project studies, namely, conducting feasibility studies in the field of drug discovery screening; design and development of computer and software in the medical and diagnostic field; computer software consultancy services in the field of diagnostics for medical purposes; medical research; design and development, installation, maintenance, updating or rental of software; programming for computers; computer technology consultancy; conversion of data and computer programs other than physical conversion; conversion of documents from a physical medium to an electronic medium; scientific research for medical purposes. services relating to cellular products for the medical field, namely, preparing in vitro tests, in particular tests for assessing hepatotoxicity/hepatic metabolism and associated mechanisms; services relating to cellular products for the medical field, namely, drug discovery screening; toxicology services, namely, analytical services related to cellular products to support for toxicity studies

Filing History

REGISTERED-PRINCIPAL REGISTER
Jan 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 23, 2021 CNEA
ASSIGNED TO EXAMINER
Aug 27, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2021 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2021 CRFA
ASSIGNED TO LIE
Jul 1, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2021 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 5, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 5, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 5, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 5, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2020 NWOS
NEW APPLICATION ENTERED
Aug 8, 2020 NWAP